Brazilian interactive design company YDreams (YD.V) jumped 23% today (at the time of writing) from $0.365 to $0.45, it’s highest point since going public earlier this year.
Peekaboo Beans (PBB.V) CEO Traci Costa has been in more newspaper and magazine articles this month than Jennifer Lawrence, it seems, and in catching that media wave, her direct sales kids clothing company has brought a new audience to the Canadian investing scene.
Battery technology company Nano One Materials (NNO.C) has enjoyed a spirited stock resurgence of late, and it’s not a surprise. With emerging tech that could take cobalt out of the rechargeable battery ingredients list, and continuing grants for their commercialization pilot project, the company is building legitimacy quickly.
Nothing inspires more vitriol, debate, and general online stick-to-it-iveness like sports talk, and those who have managed to bring together an audience have generally fared well on the financial side out of it, with big money exits and partnerships. Think Fanduel, SBNation, Draftkings, TheScore…
The short public markets life of Arcturus Growthstar Technologies Inc. (“AGS”) has been one in which investor education has played a big part. From explaining what vertical farming is, to introducing the revenue potential of cannabis grow light technology, to the impact investing nature of building indoor farms in urban areas of the United States (CSE: AGS) (OTC Pink: AGSTF) has hit a chord with a younger, more ethically and environmentally focused crowd.
I figured I knew the lithium game pretty well, but spend half an hour chatting to Chris Berry about the business and you quickly realize there’s a lot more to it.
Psst. Hey buddy, c’mere. Cannagrow Holdings (CGRW) has some stock to sell you. Smoke smoke weed weed stock stock (do the park dealers still say that when you walk by? I’m old).
It’s been a good week for Equity.Guru-covered companies. Yesterday, Golden Leaf Holdings (GLH.C) blew through multiple resistance points, hitting $0.51, up from $0.27 just a week earlier (it has slid back into the low $0.40’s since, which is a fair base).
It’s not a stock that’s been in anyone’s forethought for some time. In fact, Calyx Bio-Ventures (CYX.V) isn’t even in the bio-science business anymore, and yesterday you could have bought the entire company for the cost of a Saskatchewan condo.